In February and March of 2008, Actavis recalled several brands of fentanyl transdermal patches because they may have defects that could allow the fentanyl gel to leak out of the patch. If the gel touches patient’s or caregiver’s skin, it could cause respiratory depression and possibly death.
Fentanyl Patch Recall List
- Watson Pharmaceuticals, Inc. 75mcg/hr Fentanyl Transdermal System patches (lot 92461850; Expiration Date: 8/31/2009) sold in the United States between January 30, 2008, and March 19, 2008
- Duragesic patches sold by PriCara, and its generic equivalent sold by Sandoz – 25 mcg/hr with expiration dates of December 2009 or earlier
- Actavis patches that may have an Abrika Pharmaceuticals label – all lots are recalled, including the 25, 50, 75, and 100 mcg/hr strengths.
FDA Video: Fentanyl (Duragesic) Patches Recalled
Below is an excellent video published by the U.S. Food & Drug Administration concerning the multiple Fentanyl patch recalls that have occurred recently.
Read the Full Transcript: Fentanyl (Duragesic) Patches Recalled